Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Heron Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 176 | 1 | 162 | −13 |
| Shares | 115.8M | 117 | 107.9M | −7.86M (−6.8%) |
| Value | $289.5M | $293 | $163.1M | −$126.4M (−43.7%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 802,700 | $1.21M | 0.02% |
| Simplify Asset Management Inc. | 306,590 | $463.0K | 0.08% |
| SG Americas Securities, LLC | 100,968 | $152.0K | 0.00% |
| Quinn Opportunity Partners LLC | 92,097 | $139.1K | 0.01% |
| Point72 Asset Management, L.P. | 34,034 | $51.4K | 0.00% |
| Apeiron RIA LLC | 33,000 | $49.8K | 0.02% |
| Captrust Financial Advisors | 25,552 | $38.6K | 0.00% |
| Graham Capital Management, L.P. | 25,006 | $37.8K | 0.00% |
| PFS Investments Inc. | 14,077 | $32.0K | 0.00% |
| SEI Investments Co | 18,138 | $27.4K | 0.00% |
| Biltmore Family Office, LLC | 16,300 | $24.6K | 0.01% |
| Dynamic Advisor Solutions LLC | 10,264 | $15.5K | 0.00% |
| Clear Harbor Asset Management, LLC | 10,000 | $15.1K | 0.00% |
| WR Wealth Planners, LLC | 3,800 | $5.74K | 0.00% |
| Global Retirement Partners, LLC | 2,000 | $4.66K | 0.00% |
| GPS Wealth Strategies Group, LLC | 72 | $109 | 0.00% |
| Toronto Dominion Bank | 9 | $0 | 0.00% |
Sold out (30)
Institutions that held Heron Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held Heron Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CoreCap Advisors, LLC | 117 | $293 |